ATE383335T1 - 3-amino-pyrrolidine als inhibitoren der monoamin- wiederaufnahme - Google Patents

3-amino-pyrrolidine als inhibitoren der monoamin- wiederaufnahme

Info

Publication number
ATE383335T1
ATE383335T1 AT04750759T AT04750759T ATE383335T1 AT E383335 T1 ATE383335 T1 AT E383335T1 AT 04750759 T AT04750759 T AT 04750759T AT 04750759 T AT04750759 T AT 04750759T AT E383335 T1 ATE383335 T1 AT E383335T1
Authority
AT
Austria
Prior art keywords
reuppost
monoamine
pyrrolidine
inhibitors
amino
Prior art date
Application number
AT04750759T
Other languages
English (en)
Inventor
Christopher Beadle
M J Cases-Thomas
Barry Clark
Peter Gallagher
John Masters
Graham Timms
Magnus Walter
Maria Whatton
Virginia Wood
Jeremy Gilmore
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0313463A external-priority patent/GB0313463D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE383335T1 publication Critical patent/ATE383335T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT04750759T 2003-06-11 2004-05-11 3-amino-pyrrolidine als inhibitoren der monoamin- wiederaufnahme ATE383335T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0313463A GB0313463D0 (en) 2003-06-11 2003-06-11 Inhibitors on monoamine uptake
US51086703P 2003-10-14 2003-10-14
US52445003P 2003-11-24 2003-11-24
US52478103P 2003-11-25 2003-11-25

Publications (1)

Publication Number Publication Date
ATE383335T1 true ATE383335T1 (de) 2008-01-15

Family

ID=33556507

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04750759T ATE383335T1 (de) 2003-06-11 2004-05-11 3-amino-pyrrolidine als inhibitoren der monoamin- wiederaufnahme

Country Status (10)

Country Link
US (1) US7619096B2 (de)
EP (1) EP1638934B1 (de)
AR (1) AR044570A1 (de)
AT (1) ATE383335T1 (de)
DE (1) DE602004011221T2 (de)
ES (1) ES2298782T3 (de)
PE (1) PE20050160A1 (de)
SV (1) SV2005001805A (de)
TW (1) TW200508195A (de)
WO (1) WO2005000811A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1735302B1 (de) 2004-02-27 2010-06-16 Eli Lilly And Company 4-aminopiperidinderivate als inhibitoren der monoamin-aufnahme
US7507823B2 (en) 2004-05-06 2009-03-24 Bristol-Myers Squibb Company Process of making aripiprazole particles
WO2005118531A1 (en) 2004-06-01 2005-12-15 Eli Lilly And Company Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake
US8604055B2 (en) 2004-12-31 2013-12-10 Dr. Reddy's Laboratories Ltd. Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
MX2007007919A (es) 2004-12-31 2008-01-22 Reddy Us Therapeutics Inc Nuevos derivados de bencilaminas como inhibidores de la proteina de transferencia de colesteril-ester(cetp).
TWI410406B (zh) * 2005-05-13 2013-10-01 Otsuka Pharma Co Ltd 吡咯烷化合物
US20090215857A1 (en) * 2005-09-13 2009-08-27 Pfizer Products Inc. Therapeutic Pyrrolidines
JP5219465B2 (ja) * 2006-11-10 2013-06-26 大塚製薬株式会社 医薬
GB0701171D0 (en) * 2007-01-22 2007-02-28 Imp Innovations Ltd Compositions and uses thereof
EP2393357B1 (de) * 2009-02-09 2015-08-26 Sunovion Pharmaceuticals Inc. Pyrrolidin- triple-reuptake -inhibitoren
US8273786B2 (en) 2009-07-21 2012-09-25 Theravance, Inc. 3-phenoxymethylpyrrolidine compounds
JP5964965B2 (ja) 2011-08-18 2016-08-03 ドクター レディズ ラボラトリーズ リミテッド コレステリルエステル転送タンパク質(cetp)インヒビターとしての置換複素環式アミン化合物
IN2014CN02290A (de) 2011-09-27 2015-06-19 Reddys Lab Ltd Dr
WO2014018721A1 (en) 2012-07-25 2014-01-30 Bio-Rad Laboratories, Inc. Targeted delivery of reagents through patterned transfer sheets
TWI773657B (zh) 2015-12-18 2022-08-11 美商亞德利克斯公司 作爲非全身tgr5促效劑之經取代之4-苯基吡啶化合物
US12084472B2 (en) 2015-12-18 2024-09-10 Ardelyx, Inc. Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1100501A4 (de) * 1998-06-30 2002-12-04 Lilly Co Eli Pyrrolidine und pyrroliinederivate mit einer wirkung auf serotonin-relatierte systeme
CN1332726A (zh) 1998-11-02 2002-01-23 卫福有限公司 吡咯烷化合物及其药物用途
IL150651A0 (en) * 2000-01-20 2003-02-12 Eisai Co Ltd Nitrogen-containing cyclic compound and pharmaceutical compositions containing the same
KR100879647B1 (ko) * 2000-03-06 2009-01-20 아카디아 파마슈티칼스 인코포레이티드 세로토닌 관련 질병의 치료에 사용되는 아자시클릭 화합물
JP4619655B2 (ja) * 2001-09-14 2011-01-26 ハイ・ポイント・ファーマスーティカルズ、エルエルシー 新規アミノアゼチジン、−ピロリジンおよび−ピペリジン誘導体
JP2005533813A (ja) * 2002-06-24 2005-11-10 アカディア ファーマシューティカルズ,インコーポレーテッド セロトニン受容体作用物質としてのn−置換ピペリジン誘導体
CN1688307A (zh) * 2002-10-04 2005-10-26 Ucb公司 4-氨基哌啶衍生物,它们的制备方法和它们作为药物的用途
US20060079554A1 (en) 2002-12-06 2006-04-13 Barry Peter C Inhibitors of monomine uptake

Also Published As

Publication number Publication date
TW200508195A (en) 2005-03-01
US20060270713A1 (en) 2006-11-30
WO2005000811A1 (en) 2005-01-06
EP1638934B1 (de) 2008-01-09
US7619096B2 (en) 2009-11-17
ES2298782T3 (es) 2008-05-16
EP1638934A1 (de) 2006-03-29
DE602004011221T2 (de) 2009-01-02
PE20050160A1 (es) 2005-03-26
AR044570A1 (es) 2005-09-21
DE602004011221D1 (de) 2008-02-21
SV2005001805A (es) 2005-11-04

Similar Documents

Publication Publication Date Title
ATE437876T1 (de) Hexahydropyridoisochinoline als dpp-iv- inhibitoren
DE60329282D1 (de) Cyano-pyrrolidine als DPP-IV Inhibitoren
ATE446090T1 (de) Thiadiazolidinone als gsk3-inhibitoren
ATE401328T1 (de) Verbrückte n-arylsulfonylpiperidine als gamma- sekretaseinhibitoren
ATE525377T1 (de) Imidazoä1,5-aüpyrazine als inhibitoren von tyrosinkinase
ATE413395T1 (de) N-substituierte pyrazolyl-amidyl-benzimidazolyl-c-kit-inhibitor n
ATE489387T1 (de) Pyridoä2,1-aü-isochinolinderivate als dpp-iv inhibitoren
ATE400271T1 (de) Aryl-pyridinderivate als 11-beta-hsd1-hemmer
DE60320933D1 (de) Rho-kinase inhibitoren
ATE423121T1 (de) Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren
ATE416171T1 (de) 2-hydroxy-3-heteroarylindole derivate als gsk3 inhibitoren
DK1765327T3 (da) Forbindelser, sammensætninger og fremgangsmåder
ATE420076T1 (de) Indozolonderivate als 11b-hsd1-inhibitoren
NO20076678L (no) Glutamataggrekanaseinhibitorer
ATE452891T1 (de) Pyrimidopyrimidone als kinaseinhibitoren
ATE402934T1 (de) Malonamidderivate als gamma-secretaseinhibitoren
ATE452635T1 (de) Heteroaryl-substituierte piperidin-derivate als l-cpt1-hemmer
ATE525374T1 (de) Heteroarylsubstituierte pyrroloä2,3-büpyridine und pyrroloä2,3-büpyrimidine als januskinaseinhibitoren
ATE401893T1 (de) Thiophenepyrimidinone als 17-beta-hydroxysteroid dehydrogenase inhibitoren
NO20054852D0 (no) GFAT inhibitorer
DE602004028827D1 (de) Pyrrolodihydroisochinoline als pde10- inhibitoren
ATE419250T1 (de) 2-cyanopyrrolidincarbonsäureamide als dipeptidylpeptidase-iv-inhibitoren
ATE411306T1 (de) Biarylsulfonamide als mmp-inhibitoren
ATE462692T1 (de) 3-amino-1-arylpropyl-indole als monoamin- wiederaufnahmehemmer
ATE538787T1 (de) Benzimidazol-derivative als raf-kinase-hemmer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties